Gland Pharma share price jumped over 6.73%, hitting a 52-week high in Monday's trading session, defying the downward rally in the Indian stock market. The pharma stock opened in the green at ₹3,147 apiece on NSE today, as compared to the previous close of ₹3,132.80 on Sunday and touched an intraday high of ₹3,352 on 9 November.
Meanwhile, Indian benchmark indices Sensex and Nifty opened lower on Monday, weighed down by selling pressure in heavyweight IT stocks and profit-booking following the recent sharp rally in the equity market. The 30-share BSE Sensex fell 93.95 points to 80,919.19 in early trade, while the NSE Nifty 50 declined 30 points to 24,968.80.
Drugmaker Gland Pharma, on Friday, November 6, reported a 58.2% year-on-year (YoY) jump in net profit to ₹291 crore for the second quarter of FY27, compared with ₹184 crore in the corresponding quarter of the previous financial year.
The company's revenue increased 23.3% YoY to ₹1,834 crore from ₹1,487 crore a year earlier. EBITDA surged 54.1% to ₹484 crore, against ₹314 crore in the year-ago quarter. Consequently, the EBITDA margin improved to 26.4% from 21.1%.
On an adjusted basis, quarterly EBITDA grew 50% year-on-year, with the adjusted EBITDA margin standing at 27%. The company's profit after tax (PAT) margin also expanded by approximately 350 basis points during the quarter.